| Eric Pittelkow, MD | |
|
1200 E Michigan Ave, Lansing, MI 48912 | |
| (517) 364-5388 | |
| Not Available |
| Full Name | Eric Pittelkow |
|---|---|
| Gender | Male |
| Speciality | Plastic And Reconstructive Surgery |
| Experience | 8 Years |
| Location | 1200 E Michigan Ave, Lansing, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1982050340 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Edward W Sparrow Hospital | Lansing, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Edward W Sparrow Hospital Association | 6709799166 | 522 |
News Archive
Georgia health officials have launched a new bilingual initiative that aims to increase HIV/AIDS awareness in the state's Hispanic community and educate residents about HIV prevention and testing, the McClatchy-Tribune/Chattanooga Times Free Press reports.
Screening for a sometimes fatal condition among patients with a rare autoimmune disease could soon - thanks to a computer algorithm - become even more accurate.
Recent advances in cancer therapeutics have led to the discovery of biomarkers that can predict patient response to certain drugs. Screening for mutations in the epidermal growth factor receptor (EGRF) prior to non-small cell lung cancer treatment, for example, has been shown to indentify patients who are likely to respond to treatment with erlontinib. This maximizes the drug's impact, and spares patients who are not likely to benefit from being subjected to potentially debilitating side effects.
First trial to compare e-cigarettes with nicotine patches shows comparable success in helping smokers to quit.
› Verified 9 days ago
| Entity Name | Sparrow Clinton Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306893078 PECOS PAC ID: 5395658850 Enrollment ID: O20040301000072 |
News Archive
Georgia health officials have launched a new bilingual initiative that aims to increase HIV/AIDS awareness in the state's Hispanic community and educate residents about HIV prevention and testing, the McClatchy-Tribune/Chattanooga Times Free Press reports.
Screening for a sometimes fatal condition among patients with a rare autoimmune disease could soon - thanks to a computer algorithm - become even more accurate.
Recent advances in cancer therapeutics have led to the discovery of biomarkers that can predict patient response to certain drugs. Screening for mutations in the epidermal growth factor receptor (EGRF) prior to non-small cell lung cancer treatment, for example, has been shown to indentify patients who are likely to respond to treatment with erlontinib. This maximizes the drug's impact, and spares patients who are not likely to benefit from being subjected to potentially debilitating side effects.
First trial to compare e-cigarettes with nicotine patches shows comparable success in helping smokers to quit.
› Verified 9 days ago
| Entity Name | Edward W Sparrow Hospital Association |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033165790 PECOS PAC ID: 6709799166 Enrollment ID: O20050210000079 |
News Archive
Georgia health officials have launched a new bilingual initiative that aims to increase HIV/AIDS awareness in the state's Hispanic community and educate residents about HIV prevention and testing, the McClatchy-Tribune/Chattanooga Times Free Press reports.
Screening for a sometimes fatal condition among patients with a rare autoimmune disease could soon - thanks to a computer algorithm - become even more accurate.
Recent advances in cancer therapeutics have led to the discovery of biomarkers that can predict patient response to certain drugs. Screening for mutations in the epidermal growth factor receptor (EGRF) prior to non-small cell lung cancer treatment, for example, has been shown to indentify patients who are likely to respond to treatment with erlontinib. This maximizes the drug's impact, and spares patients who are not likely to benefit from being subjected to potentially debilitating side effects.
First trial to compare e-cigarettes with nicotine patches shows comparable success in helping smokers to quit.
› Verified 9 days ago
| Entity Name | Edward W Sparrow Hospital Association |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457744666 PECOS PAC ID: 6709799166 Enrollment ID: O20150529000465 |
News Archive
Georgia health officials have launched a new bilingual initiative that aims to increase HIV/AIDS awareness in the state's Hispanic community and educate residents about HIV prevention and testing, the McClatchy-Tribune/Chattanooga Times Free Press reports.
Screening for a sometimes fatal condition among patients with a rare autoimmune disease could soon - thanks to a computer algorithm - become even more accurate.
Recent advances in cancer therapeutics have led to the discovery of biomarkers that can predict patient response to certain drugs. Screening for mutations in the epidermal growth factor receptor (EGRF) prior to non-small cell lung cancer treatment, for example, has been shown to indentify patients who are likely to respond to treatment with erlontinib. This maximizes the drug's impact, and spares patients who are not likely to benefit from being subjected to potentially debilitating side effects.
First trial to compare e-cigarettes with nicotine patches shows comparable success in helping smokers to quit.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Eric Pittelkow, MD 1200 E Michigan Ave, Lansing, MI 48912-1800 Ph: (517) 364-5388 | Eric Pittelkow, MD 1200 E Michigan Ave, Lansing, MI 48912 Ph: (517) 364-5388 |
News Archive
Georgia health officials have launched a new bilingual initiative that aims to increase HIV/AIDS awareness in the state's Hispanic community and educate residents about HIV prevention and testing, the McClatchy-Tribune/Chattanooga Times Free Press reports.
Screening for a sometimes fatal condition among patients with a rare autoimmune disease could soon - thanks to a computer algorithm - become even more accurate.
Recent advances in cancer therapeutics have led to the discovery of biomarkers that can predict patient response to certain drugs. Screening for mutations in the epidermal growth factor receptor (EGRF) prior to non-small cell lung cancer treatment, for example, has been shown to indentify patients who are likely to respond to treatment with erlontinib. This maximizes the drug's impact, and spares patients who are not likely to benefit from being subjected to potentially debilitating side effects.
First trial to compare e-cigarettes with nicotine patches shows comparable success in helping smokers to quit.
› Verified 9 days ago
Dr. Douglas Hintzman, D.O. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2815 S Pennsylvania Ave, Suite 5, Lansing, MI 48910 Phone: 517-372-0300 | |
Dr. George Peter Poletes, M.D. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1219 E Saginaw St, Lansing, MI 48906 Phone: 517-485-3583 Fax: 517-485-3942 |